Former President of the University of South Carolina Joins Collexis’ Board of Directors
November 17, 2008
COLUMBIA, SC – November 17, 2008 – Collexis Holdings Inc. (OTCBB: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that former president of the University of South Carolina, Dr. Andrew Sorensen has joined the company’s Board of Directors.
“We’re honored to have Dr. Sorensen join our Board of Directors,” said Bill Kirkland, CEO of Collexis Holdings, Inc. “His leadership experience at The University of South Carolina, Johns Hopkins University and many other institutions will be a huge asset to Collexis as the academic and government markets represent a major area of our growth.
Sorensen retired as President of The University of South Carolina in June 2008. He continues to serve as a distinguished professor at the University’s School of Medicine.
“Through my involvement with The University of South Carolina and Health Sciences South Carolina, I’ve seen firsthand how Collexis is creating a virtual knowledge directory of statewide biomedical research,” said Sorensen. “I’m pleased to join a company whose technology enhances collaboration, the sharing of knowledge, and ultimately helps to improve the health and well-being of South Carolina citizens.”
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world’s first pre-populated scientific social network for life science researchers, www.biomedexperts.com.
Collexis’ proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.”
Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’ current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense.
Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.
